GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OS Therapies Inc (AMEX:OSTX) » Definitions » Net Issuance of Preferred Stock

OSTX (OS Therapies) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is OS Therapies Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

OS Therapies's net issuance of preferred for the three months ended in Sep. 2024 was $0.00 Mil. The number is 0, which means that OS Therapies has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

OS Therapies's net issuance of preferred for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

OS Therapies Net Issuance of Preferred Stock Historical Data

The historical data trend for OS Therapies's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OS Therapies Net Issuance of Preferred Stock Chart

OS Therapies Annual Data
Trend Dec21 Dec22 Dec23
Net Issuance of Preferred Stock
- - -

OS Therapies Quarterly Data
Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OS Therapies Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OS Therapies Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of OS Therapies's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

OS Therapies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OS Therapies Inc (AMEX:OSTX) » Definitions » Net Issuance of Preferred Stock
Comparable Companies
TPST SRZN OKYO RNXT CASI ATNM ELEV HSTC NRXP CVKD VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
15825 Shady Grove Road, Suite 135, Rockville, MD, USA, 20850
Website
https://www.ostherapies.com
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.